This page shows the details of why an item matched the keywords from your search.
| Item Type | Name |
|
Concept
|
Interferon-alpha
|
|
Academic Article
|
A phase I trial of intermittent high-dose alpha-interferon and dexamethasone in metastatic renal cell carcinoma.
|
|
Academic Article
|
Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinoma.
|
|
Academic Article
|
Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer.
|
|
Academic Article
|
Phase I study of interleukin-2 combined with interferon-alpha and 5-fluorouracil in patients with metastatic renal cell cancer.
|
|
Academic Article
|
5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimen.
|
|
Academic Article
|
Surgery following response to interferon-alpha-based therapy for residual renal cell carcinoma.
|
|
Academic Article
|
Treatment of chemotherapy-refractory metastatic urothelial tumors.
|
|
Academic Article
|
The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancer.
|
|
Academic Article
|
Neoadjuvant cisplatin and interferon-alpha 2B in the treatment and organ preservation of penile carcinoma.
|
|
Academic Article
|
Collecting duct carcinoma of the kidney.
|
|
Academic Article
|
Phase II trial of 5-fluorouracil, interferon-alpha and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma.
|
|
Academic Article
|
Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, alpha-interferon, cisplatin (FAP).
|
|
Academic Article
|
A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma.
|
|
Academic Article
|
Fluorouracil and recombinant human interferon alfa-2a in the treatment of metastatic chemotherapy-refractory urothelial tumors.
|
|
Academic Article
|
Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma.
|
|
Academic Article
|
Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer.
|